Endocrine System Diseases  >>  Symlin (pramlintide)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Symlin (pramlintide) / AstraZeneca
NCT00108004: Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus

Completed
3b
400
US
pramlintide acetate
AstraZeneca
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
06/05
06/05
NCT00042458: Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control

Completed
3
296
US
Pramlintide acetate, Placebo
AstraZeneca
Diabetes Mellitus, Type 1
03/03
03/03
NCT00107107: Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus

Completed
3
190
US
pramlintide acetate
AstraZeneca
Diabetes Mellitus, Type 1
06/05
06/05

Download Options